- Bridge and Butterfly Network signed a multi-year R&D agreement.
- Bridge will license Butterfly's Ultrasound-on-Chip technology.
- The agreement includes payments for technology access, development milestones, and hardware purchase commitments.
- Bridge is enrolling participants in its first human research study in Redwood City, California.
- Bridge is backed by General Catalyst, reMind Capital, Sunflower Capital, and Scott Sandell.
- Butterfly Network is listed on NYSE under BFLY.
The headline and the read are open. The reasons are one free account away, on every story.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
BORSAPLUSWhy it matters · Bull and bear case · Reaction against SPY and the sector · What to watch
Create a free account · no card 